chr12-2053565-G-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_000719.7(CACNA1C):c.3G>T(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.000000692 in 1,445,040 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 31)
Exomes 𝑓: 6.9e-7 ( 0 hom. )
Consequence
CACNA1C
NM_000719.7 start_lost
NM_000719.7 start_lost
Scores
8
2
5
Clinical Significance
Conservation
PhyloP100: 5.87
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.3G>T | p.Met1? | start_lost | 1/47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.3G>T | p.Met1? | start_lost | 1/47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.3G>T | p.Met1? | start_lost | 1/47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.3G>T | p.Met1? | start_lost | 1/47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000406454.8 | c.3G>T | p.Met1? | start_lost | 1/48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.3G>T | p.Met1? | start_lost | 1/47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000347598.9 | c.3G>T | p.Met1? | start_lost | 1/49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.3G>T | p.Met1? | start_lost | 1/47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.3G>T | p.Met1? | start_lost | 1/48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.3G>T | p.Met1? | start_lost | 1/48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000399638.5 | c.3G>T | p.Met1? | start_lost | 1/48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.3G>T | p.Met1? | start_lost | 1/48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.3G>T | p.Met1? | start_lost | 1/48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.3G>T | p.Met1? | start_lost | 1/47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.3G>T | p.Met1? | start_lost | 1/47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.3G>T | p.Met1? | start_lost | 1/47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.3G>T | p.Met1? | start_lost | 1/47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.3G>T | p.Met1? | start_lost | 1/47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.3G>T | p.Met1? | start_lost | 1/46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.3G>T | p.Met1? | start_lost | 1/46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.3G>T | p.Met1? | start_lost | 1/46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.3G>T | p.Met1? | start_lost | 1/47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.3G>T | p.Met1? | start_lost | 1/47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.3G>T | p.Met1? | start_lost | 1/47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.3G>T | p.Met1? | start_lost | 1/47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.3G>T | p.Met1? | start_lost | 1/47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.3G>T | p.Met1? | start_lost | 1/47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.3G>T | p.Met1? | start_lost | 1/46 | ENSP00000507309.1 | ||||
CACNA1C | ENST00000682544.1 | c.140-61659G>T | intron_variant | ENSP00000507184.1 | ||||||
CACNA1C | ENST00000683824.1 | c.140-61659G>T | intron_variant | ENSP00000507867.1 | ||||||
CACNA1C | ENST00000682462.1 | c.140-61659G>T | intron_variant | ENSP00000507105.1 | ||||||
CACNA1C | ENST00000683781.1 | c.140-61659G>T | intron_variant | ENSP00000507434.1 | ||||||
CACNA1C | ENST00000683840.1 | c.140-61659G>T | intron_variant | ENSP00000507612.1 | ||||||
CACNA1C | ENST00000683956.1 | c.140-61659G>T | intron_variant | ENSP00000506882.1 | ||||||
CACNA1C | ENST00000480911.6 | n.3G>T | non_coding_transcript_exon_variant | 1/27 | 5 | ENSP00000437936.2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome AF: 6.92e-7 AC: 1AN: 1445040Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 717176
GnomAD4 exome
AF:
AC:
1
AN:
1445040
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
717176
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 22, 2023 | This sequence change affects the initiator methionine of the CACNA1C mRNA. The next in-frame methionine is located at codon 8. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CACNA1C-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationTaster
Benign
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
PROVEAN
Benign
N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N
REVEL
Pathogenic
Sift
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Sift4G
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Polyphen
0.39, 0.025, 0.11, 0.66
.;B;.;B;B;B;B;B;B;B;B;P;B;B;B;B;.;B;B;.;.;.;.
Vest4
MutPred
Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);Gain of catalytic residue at T6 (P = 0.0107);
MVP
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.